164 related articles for article (PubMed ID: 2784353)
1. In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.
Starling JJ; Maciak RS; Hinson NA; Nichols CL; Briggs SL; Laguzza BC
Cancer Immunol Immunother; 1989; 28(3):171-8. PubMed ID: 2784353
[TBL] [Abstract][Full Text] [Related]
2. The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studies.
Petersen BH; DeHerdt SV; Schneck DW; Bumol TF
Cancer Res; 1991 May; 51(9):2286-90. PubMed ID: 2015593
[TBL] [Abstract][Full Text] [Related]
3. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen.
Starling JJ; Maciak RS; Hinson NA; Nichols CL; Briggs SL; Laguzza BC; Smith W; Corvalan JR
Bioconjug Chem; 1992; 3(4):315-22. PubMed ID: 1382618
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of monoclonal antibody-drug conjugate binding by flow cytometry.
Marder P; Apelgren LD; Bumol TF
J Immunol Methods; 1987 Feb; 96(2):165-70. PubMed ID: 3492560
[TBL] [Abstract][Full Text] [Related]
6. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
7. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.
Okazaki M; Luo Y; Han T; Yoshida M; Seon BK
Blood; 1993 Jan; 81(1):84-94. PubMed ID: 8417805
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs.
Apelgren LD; Bailey DL; Briggs SL; Barton RL; Guttman-Carlisle D; Koppel GA; Nichols CL; Scott WL; Lindstrom TD; Baker AL
Bioconjug Chem; 1993; 4(2):121-6. PubMed ID: 7873643
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.
Watanabe Y; Endo K; Koizumi M; Kawamura Y; Saga T; Sakahara H; Kuroki M; Matsuoka Y; Konishi J
Cancer Res; 1989 Jun; 49(11):2884-9. PubMed ID: 2470499
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia.
Ball ED; Bernier GM; Cornwell GG; McIntyre OR; O'Donnell JF; Fanger MW
Blood; 1983 Dec; 62(6):1203-10. PubMed ID: 6605773
[TBL] [Abstract][Full Text] [Related]
11. Influence of cocktails of labeled monoclonal antibodies on the localization of antibodies in human tumor xenografts.
Watanabe Y; Endo K; Saga T; Koizumi M; Sakahara H; Nakai T; Hosono M; Yao ZS; Kuroki M; Matsuoka Y
Jpn J Cancer Res; 1990 Mar; 81(3):266-71. PubMed ID: 2112530
[TBL] [Abstract][Full Text] [Related]
12. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
Ceriani RL; Blank EW
Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
14. Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
Meyer DL; Jungheim LN; Law KL; Mikolajczyk SD; Shepherd TA; Mackensen DG; Briggs SL; Starling JJ
Cancer Res; 1993 Sep; 53(17):3956-63. PubMed ID: 8358723
[TBL] [Abstract][Full Text] [Related]
15. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of anti-anti-idiotypic monoclonal antibody ("Ab1-like Ab3") in relation to carcinoembryonic antigen.
Tsujisaki M; Masuya J; Okada Y; Jinnohara T; Sasaki S; Yachi A; Imai K
J Clin Lab Anal; 2002; 16(6):279-89. PubMed ID: 12424800
[TBL] [Abstract][Full Text] [Related]
17. New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.
Laguzza BC; Nichols CL; Briggs SL; Cullinan GJ; Johnson DA; Starling JJ; Baker AL; Bumol TF; Corvalan JR
J Med Chem; 1989 Mar; 32(3):548-55. PubMed ID: 2783975
[TBL] [Abstract][Full Text] [Related]
18. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
Smyth MJ; Foster HM; Andrew SM; Teh JG; Krauer K; McKenzie IF; Pietersz GA
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():167-79. PubMed ID: 8349300
[TBL] [Abstract][Full Text] [Related]
19. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D
Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828
[TBL] [Abstract][Full Text] [Related]
20. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
Tsujisaki M; Imai K; Tokuchi S; Hanzawa Y; Ishida T; Kitagawa H; Hinoda Y; Yachi A
Cancer Res; 1991 May; 51(10):2599-604. PubMed ID: 2021940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
